Renal carcinoid tumor: An immunohistochemical and molecular genetic study of four cases

Naoto Kuroda1, Isabel Alvarado-Cabrero, Radek Sima

  • 1Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi 780-8562, Japan.

Oncology Letters
|September 12, 2012
PubMed

Insights

Genetic analysis of renal carcinoid tumors suggests chromosome 3 abnormalities are involved in their development. Further research is needed to understand the pathogenesis of these rare kidney tumors.

Area of Science:

  • Nephrology
  • Oncology
  • Genetics

Background:

  • Renal carcinoid tumors are rare neoplasms.
  • Limited genetic studies exist for renal carcinoid tumors.

Purpose of the Study:

  • To investigate the genetic alterations in renal carcinoid tumors.
  • To explore the potential role of chromosome abnormalities in tumor pathogenesis.

Main Methods:

  • Immunohistochemical and genetic examinations were performed on four renal carcinoid tumors.
  • Techniques included fluorescence in situ hybridization (FISH) and PCR-based microsatellite analysis.
  • VHL gene status was also assessed.

Main Results:

  • Tumors showed characteristic neuroendocrine markers (chromogranin A, synaptophysin).
  • Three of four tumors exhibited monosomy of chromosome 3 (D3Z1).
  • One tumor displayed monosomy of chromosome 13.
  • Loss of heterozygosity on chromosome 3p was observed in one tumor.

Conclusions:

  • Chromosome 3 abnormalities are implicated in the pathogenesis of renal carcinoid tumors.
  • Further investigation into the genetic landscape of these tumors is warranted.